Hemophilia B Gene Therapy Market Growing at CAGR of 34.10% From 2023 To 2032
As per the current market research conducted by the CMI Team, the global Hemophilia B Gene Therapy Market size is expected to record a CAGR of 34.1% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 223.4 million. By 2032, the valuation is anticipated to reach USD 5,938.5 million. Hemophilia B Gene Therapy…
Read More “Hemophilia B Gene Therapy Market Growing at CAGR of 34.10% From 2023 To 2032” »